SCHEMBL16570340

SCHEMBL16570340

CN(c1nccnc1Cn1ccc2cnc(Nc3ccc(N4CCNCC4)cc3)nc21)S(C)(=O)=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STAT6 P42226 9/20 0.58
▸ JAK2 O60674 8/20 0.52
▸ BRD4 O60885 7/20 0.52
▸ JAK3 P52333 3/20 0.51
▸ JAK1 P23458 2/20 0.51
▸ BRD2 P25440 2/20 0.51
▸ BRD3 Q15059 2/20 0.51
▸ BRDT Q58F21 2/20 0.51
▸ CDK4 P11802 3/20 0.49
▸ CCNA2 P20248 3/20 0.49
▸ CCND1 P24385 3/20 0.49
▸ CDK2 P24941 3/20 0.49
▸ PTK2 Q05397 1/20 0.46
▸ FGFR1 P11362 2/20 0.46
▸ FGFR2 P21802 2/20 0.46
▸ FGFR4 P22455 2/20 0.46
▸ FGFR3 P22607 2/20 0.46
▸ CCNE2 O96020 1/20 0.46
▸ CCNE1 P24864 1/20 0.46
▸ CCND2 P30279 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16570350 0.91 STAT6 (0.57) STAT6JAK2BRD4JAK3JAK1
SCHEMBL16570298 0.91 STAT6 (0.57) STAT6JAK2BRD4JAK3JAK1
SCHEMBL16570270 0.91 STAT6 (0.57) STAT6JAK2BRD4JAK3JAK1
SCHEMBL16580769 0.90 STAT6 (0.47) STAT6JAK2BRD4JAK3JAK1
SCHEMBL16581016 0.90 STAT6 (0.47) STAT6JAK2BRD4JAK3JAK1
SCHEMBL16570262 0.90 STAT6 (0.47) STAT6JAK2BRD4JAK3JAK1
SCHEMBL16570819 0.90 STAT6 (0.60) STAT6JAK2BRD4JAK3JAK1
SCHEMBL16570834 0.90 STAT6 (0.56) STAT6JAK2BRD4JAK3JAK1
SCHEMBL16570374 0.90 STAT6 (0.62) STAT6JAK2BRD4JAK3JAK1
SCHEMBL16570091 0.89 STAT6 (0.55) STAT6JAK2BRD4JAK3JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160222014-A1 COMPOUNDS FOR REGULATING FAK AND/OR SRC PATHWAYS ASANA BIOSCIENCES, LLC (US) 2016-08-04 — — US claimed
WO-2015038417-A1 COMPOUNDS FOR REGULATING FAK AND/OR SRC PATHWAYS ASANA BIOSCIENCES, LLC (US) 2015-03-19 — — WO claimed
US-20160222014-A1 COMPOUNDS FOR REGULATING FAK AND/OR SRC PATHWAYS ASANA BIOSCIENCES, LLC (US) 2016-08-04 — — US disclosed
US-20160222014-A1 COMPOUNDS FOR REGULATING FAK AND/OR SRC PATHWAYS ASANA BIOSCIENCES, LLC (US) 2016-08-04 — — US disclosed
US-20160222014-A1 COMPOUNDS FOR REGULATING FAK AND/OR SRC PATHWAYS ASANA BIOSCIENCES, LLC (US) 2016-08-04 — — US disclosed
WO-2015038417-A1 COMPOUNDS FOR REGULATING FAK AND/OR SRC PATHWAYS ASANA BIOSCIENCES, LLC (US) 2015-03-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160222014-A1 COMPOUNDS FOR REGULATING FAK AND/OR SRC PATHWAYS SRC, PTK2, FYN STAT6 103/4885JAK2 9/4885BRD4 427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback